Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Menopause affects hair and skin; more research needed for treatment.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Different hair removal methods have pros and cons, and more evidence is needed to prove laser treatments work.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

New acne treatments show promise as alternatives to traditional therapies.

More research is needed to determine if iron deficiency causes hair loss.

Managing PCOS is hard because it varies a lot, treatments are limited, and there's a lot of false information online.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Acne is an important sign of androgen excess disorders in women.